Is Axsome Therapeutics Stock a Millionaire Maker? Here's What the Numbers Say.
The stock has soared more than 220% in three years.
Overview
Axsome Therapeutics (NASDAQ: AXSM) has been going through a particularly significant growth phase in recent years, launching drugs for central nervous system (CNS) conditions and pushing several candidates through late-stage clinical trials. Investors have recognized the company's potential and piled into the stock -- it's climbed more than 220% over the past three years.
And considering these product launches are pretty recent, and any pipeline success could produce new revenue drivers, it's fair to say this biopharma company is in the early days of its growth story. Considering this, is Axsome stock a millionaire maker? Let's take a look at what the numbers say.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.